ES8801902A1 - Un procedimiento para la preparacion de agentes inotropicos de quinolona - Google Patents

Un procedimiento para la preparacion de agentes inotropicos de quinolona

Info

Publication number
ES8801902A1
ES8801902A1 ES557430A ES557430A ES8801902A1 ES 8801902 A1 ES8801902 A1 ES 8801902A1 ES 557430 A ES557430 A ES 557430A ES 557430 A ES557430 A ES 557430A ES 8801902 A1 ES8801902 A1 ES 8801902A1
Authority
ES
Spain
Prior art keywords
inotropic agents
hetk
quinolone
quinolone inotropic
quinonolas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557430A
Other languages
English (en)
Other versions
ES557430A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES8801902A1 publication Critical patent/ES8801902A1/es
Publication of ES557430A0 publication Critical patent/ES557430A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Steroid Compounds (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

QUINONOLAS (I), SE OBTIENEN POR REACCION DE UN COMPUESTO (II) CON OTRO (III), EN PRESENCIA DE PD (PPH3)4 Y UN DISOLVENTE COMO EL THF, EN ATMOSFERA DE NITROGENO; DONDE R1 ES -NR4R5, -SO2NR4R5, HETK Y OTROS; R4 Y R5 SON H O C1-4, HETK ES UN HETEROCICLO NITROGENADO DE 5 O 6 MIEMBROS; R2, R3 Y X SON H, ALQUILO C1-4 Y ITROS Y HAL ES BR O I. SON REFORZADORES DE LA CONTRACCION DEL MIOCARDIO Y NO PRODUCEN AUMENTOS SIGNIFICATIVOS DEL RITMO CARDIACO POR LO QUE SE APLICAN AL TRATAMIENTO DE LA INSUFICIENCIA CARDIACA.
ES557430A 1985-01-30 1987-02-27 Un procedimiento para la preparacion de agentes inotropicos de quinolona Expired ES8801902A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858502267A GB8502267D0 (en) 1985-01-30 1985-01-30 Quinolone inotropic agents
CN85104392A CN85104392B (zh) 1985-01-30 1985-06-10 喹诺酮变力剂的制备方法

Publications (2)

Publication Number Publication Date
ES8801902A1 true ES8801902A1 (es) 1988-03-01
ES557430A0 ES557430A0 (es) 1988-03-01

Family

ID=25741743

Family Applications (2)

Application Number Title Priority Date Filing Date
ES551343A Expired ES8706122A1 (es) 1985-01-30 1986-01-28 Un procedimiento para la preparacion de agentes inotropicos de quinolona
ES557430A Expired ES8801902A1 (es) 1985-01-30 1987-02-27 Un procedimiento para la preparacion de agentes inotropicos de quinolona

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES551343A Expired ES8706122A1 (es) 1985-01-30 1986-01-28 Un procedimiento para la preparacion de agentes inotropicos de quinolona

Country Status (18)

Country Link
US (1) US4728654A (es)
EP (1) EP0190857B1 (es)
JP (1) JPS61176568A (es)
KR (1) KR880000132B1 (es)
CN (1) CN85104392B (es)
AT (1) ATE51224T1 (es)
AU (1) AU557667B2 (es)
CA (1) CA1255662A (es)
DE (1) DE3669714D1 (es)
DK (1) DK43286A (es)
ES (2) ES8706122A1 (es)
FI (1) FI860424A7 (es)
GB (1) GB8502267D0 (es)
GR (1) GR860249B (es)
HU (1) HU194831B (es)
IE (1) IE860258L (es)
PL (1) PL257669A1 (es)
PT (1) PT81921B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582909A (en) * 1984-02-02 1986-04-15 Warner-Lambert Company Benzobicyclic lactam acids and derivatives as cognition activators
US4797490A (en) * 1984-12-06 1989-01-10 Pfizer Inc. Process for the preparation of 3-(2'-fluorophenyl)pyridine
GB8709448D0 (en) * 1987-04-21 1987-05-28 Pfizer Ltd Heterobicyclic quinoline derivatives
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−３，４−ジヒドロカルボスチリル誘導体
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
CN102532015B (zh) * 2012-01-18 2013-10-23 云南大学 香豆素及其类似物的固相合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3287459A (en) * 1961-10-23 1966-11-22 Chattanooga Medicine Co Carbostyrils, coumarines and thiocoumarines
US3668207A (en) * 1970-01-22 1972-06-06 Ciba Geigy Corp 2-amino-4-aryl-quinolines
DE2123923A1 (de) * 1971-05-14 1972-11-23 Boehringer Mannheim Gmbh, 6800 Mannheim 4-eckige Klammer auf omega- (Flavon-7yl-oxy) -alkyl eckige Klammer zu -pigerazin-Derivate und Verfahren zu ihrer Herstellung
BE884459Q (fr) * 1971-05-14 1981-01-26 Boehringer Mannheim Gmbh Derives de la 4-(omega-(coumarine-7-yl-oxy)-alkyl)-piperazine et procede de preparation
JPS4976877A (es) * 1972-11-28 1974-07-24
US4004012A (en) * 1975-10-14 1977-01-18 Sterling Drug Inc. 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones
DE2827566A1 (de) * 1978-06-23 1980-01-10 Boehringer Mannheim Gmbh 1,2-dihydro-chinolin-2-on-derivate und verfahren zu ihrer herstellung
HU190412B (en) * 1981-09-17 1986-09-29 Warner-Lambert Co,Us Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones
IL69407A (en) * 1982-08-23 1987-10-20 Warner Lambert Co 2(1h)-pyridinones,their preparation and pharmaceutical compositions containing them
US4503061A (en) * 1983-07-22 1985-03-05 Warner-Lambert Company Substituted phenyl-pyridinones as cardiotonic agents
US4550119A (en) * 1983-05-23 1985-10-29 Warner-Lambert Company 2,4-Dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones
US4710507A (en) * 1983-12-22 1987-12-01 Pfizer Inc. Quinolone inotropic agents
CA1292234C (en) * 1984-05-29 1991-11-19 Simon Fraser Campbell Heterocyclic-substituted quinolone inotropic agents

Also Published As

Publication number Publication date
US4728654A (en) 1988-03-01
DK43286A (da) 1986-07-31
PT81921A (en) 1986-02-01
GR860249B (en) 1986-05-29
AU557667B2 (en) 1987-01-08
PL257669A1 (en) 1987-05-18
DK43286D0 (da) 1986-01-29
JPS61176568A (ja) 1986-08-08
IE860258L (en) 1986-07-30
EP0190857A2 (en) 1986-08-13
HU194831B (en) 1988-03-28
FI860424A7 (fi) 1986-07-31
CN85104392B (zh) 1988-02-17
CA1255662A (en) 1989-06-13
KR880000132B1 (ko) 1988-03-12
AU5279886A (en) 1986-08-07
FI860424A0 (fi) 1986-01-29
ATE51224T1 (de) 1990-04-15
HUT40421A (en) 1986-12-28
PT81921B (en) 1987-11-16
EP0190857A3 (en) 1987-08-19
KR860005790A (ko) 1986-08-13
EP0190857B1 (en) 1990-03-21
ES551343A0 (es) 1987-06-01
DE3669714D1 (de) 1990-04-26
GB8502267D0 (en) 1985-02-27
CN85104392A (zh) 1986-12-24
ES557430A0 (es) 1988-03-01
ES8706122A1 (es) 1987-06-01

Similar Documents

Publication Publication Date Title
ES2066991T3 (es) Agentes hipoglucemiantes de oxazolidinadiona.
ATE57946T1 (de) Schlagzaehe polyamid-formmassen.
YU46960B (sh) Novi estri alginske kiseline
FI852974A0 (fi) Nya n-hydroxylgruppen skyddande grupper och framstaellningsfoerfarande foer 3-acylamino-1-hydroxi-2-azetidinoner.
ES2061587T3 (es) Compuestos aromaticos y heteroaromaticos alfa,alfa-disustituidos como mejoradores de la cognicion.
NL971014I1 (nl) Heterocyclische verbindingen.
ES8304095A1 (es) Un procedimiento para la preparacion de derivados de quinazolina.
ES2066808T3 (es) Derivados de quinoleina, su produccion y uso.
ES8702403A1 (es) Un procedimiento para la preparacion de nuevas n-((4-piperidinil)alquil)oxazol y tiazolaminas condensadas biciclicas sustituidas
FI882919A0 (fi) Foerfarande.
SE7411888L (es)
ES2099800T3 (es) Dihidropiridinas utilizables en la terapia antitumoral.
ES8801902A1 (es) Un procedimiento para la preparacion de agentes inotropicos de quinolona
ES8601202A1 (es) Procedimiento para la produccion de espirosuccinimidas
ATE78830T1 (de) Lactamderivate, deren herstellung und deren benutzung als hypotensive mittel.
DE3879429D1 (de) Cyclopropanderivate.
ES8605507A1 (es) Un compuesto de 3-indolcarboxamida
DK226285A (da) Beta-lactamforbindelser, deres fremstilling og anvendelse som laegemidler eller vaekstfremmende midler til dyr samt mellemprodukter til fremstillingen
ATE93540T1 (de) Menschliche pankreaselastase i.
ES8603876A1 (es) Derivados de pirazol-piridina
FR2391235A1 (fr) Utilisation d'amidines, comme accelerateurs de reaction, lors de la preparation de polyurees
ES2063324T3 (es) Derivados del acido butirico.
JPS6442468A (en) Substituted pyridylethanolamine, manufacture and use as livestock yield promoter
FI820292L (fi) Nya bis- och polydisulfider vilka har immunostimulerande aktivitet
ES8708226A1 (es) Procedimiento para la produccion de derivados de 1,4-dihi- dropiridina